LBL Biotech Overview
- Headquarters
- Tw
- Website
- www.lblbio.com
- Industry
- Biotechnology Research
- Employees
- 1
- Founded
- 2019
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About LBL Biotech
LBL Biotech is developing a combination therapy treatment targeting pancreatic cancer. Our proprietary technology combines IL-20 antibody with an immune checkpoint PD-1 antibody to attenuate tumors and has delivered excellent efficacy in treating liver cancer, breast cancer, cancer-induced cachexia (CAC), chemotherapy-induced neurological disease, and spinal cord injuries.
LBL Biotech Contact Details
- People in AeroLeads
- 1
LBL Biotech Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Ming-Shi Chang | Founder & Chief Executive Officer | Taiwan, Province of China |
View
|
Compare Similar Companies to LBL Biotech
HanchorBio Inc. 漢康生技股份有限公司
Biotechnology Research
Help Therapeutics
Biotechnology
DotBio
Biotechnology Research
MxT Biotech
Biotechnology Research
United Immunity, Co., Ltd.
Biotechnology Research
AmMax Bio., Inc.
Pharmaceutical Manufacturing
Cellusion Inc.
Biotechnology Research
Onward Therapeutics
Biotechnology Research
Apeximmune Therapeutics
Biotechnology Research
Cyto-Facto Inc.
Pharmaceutical Manufacturing